THERAPEUTICS
Intensive glucose control did not prevent important complications in type 2 diabetes
| The first 150 words of the full text of this article appear below. |
A Patel
Dr A Patel, University of Sydney, Sydney, New South Wales, Australia; apatel@george.org.au
STUDY DESIGN
randomised controlled trial (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation [ADVANCE]).
concealed.*
blinded (outcome adjudication committee).*
STUDY QUESTION
215 centres in 20 countries in Asia, Australasia, Europe, and North America.
11 140 patients 
55 years of age (mean age 66 y, 58% men) who had type 2 diabetes and a history of, or risk factors for, vascular disease. Patients requiring insulin were excluded.
intensive glucose control with gliclazide modified-release, 30–120 mg/d, and other non-sulfonylurea drugs as needed to achieve a target glycated haemoglobin concentration 
6.5% (n = 5571) or standard glucose control with drugs other than gliclazide (n = 5569).
composite of macrovascular events (non-fatal myocardial infarction or stroke, or death from cardiovascular causes) and composite of microvascular events (new or worsening nephropathy [including macroalbuminuria] or retinopathy). Secondary outcomes included new-onset microalbuminuria
Mayo Clinic, Rochester, Minnesota, USA
Universidad Peruana Cayetano Heredia, Lima, Peru
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
